Part A: You are an ambulatory care pharmacist who works in an internal medicine office practice. One of the physicians has asked you to talk with their patient, Shawn Franklin, age 55. They have a PMH of arthritis, Type 2 diabetes, dyslipidemia, and hypertension. The physician reports having trouble maintaining control over the patients various conditions. The physician asks you to evaluate the patient and make recommendations to help improve control. Based on the information, you believe the patient may have some medication adherence issues. A summary of their recent visits and medications are below. May 2024Meds at start of visit:Acetaminophen 500 mg 2T PRN pain (no more than 3 times a day)Amlodipine 5 mg QAMHCTZ 25 mg QAMLosartan 50 mg QAMMetformin 500 mg BIDAtorvastatin 10 mg QHS Objective Data:BP: 186/90HgbA1c: 9.5%INR: 1.4LDL: 150 Plan:1. Increase losartan to 100 mg QAM2. Increase metformin to 1000 mg BID3. Increase atorvastatin to 20 mg QHS August 2024Meds at start of visit:Acetaminophen 500 mg 2T PRN pain (no more than 3 times a day)Amlodipine 5 mg QAMHCTZ 25 mg QAMLosartan 100 mg QAMMetformin 1000 mg BIDAtorvastatin 20 mg QHS Objective Data:BP: 174/86HgbA1c: 8.9%INR: 1.5 Plan:1. Add glipizide 5 mg po BID with lunch and dinner November 2024Meds at start of visit:Acetaminophen 500 mg 2T PRN pain (no more than 3 times a day)Amlodipine 5 mg QAMHCTZ 25 mg QAMLosartan 100 mg QAMMetformin 1000 mg BIDAtorvastatin 20 mg QHSGlipizide 5 mg BID before lunch and dinner Objective Data:BP: 174/88HgbA1c: 8.5%LDL: 145 Plan:1. Add Januvia 100 mg PO QAM2. Add ezetimibe 10 mg PO QHS3. Increase amlodipine to 10 mg QAM February 2025Meds at start of visit:Amlodipine 10 mg QAMHCTZ 25 mg QAMLosartan 100 mg QAMMetformin 1000 mg BIDAtorvastatin 20 mg QHSGlipizide 5 mg BID before lunch and dinnerJanuvia 100 mg QAMEzetimibe 10 mg QHS Objective Data:BP: 170/86HgbA1c: 8.4% 1. What information would be important to collect from this patient before making a recommendation? Include specific questions you would ask the patient. 2. During the conversation with the patient, you find out they have gotten very frustrated with all the new medicines and changes the doctor is making at every visit, and its hard for them to afford all these medicines. How would you adjust your communication with this patient to successfully address his concerns? Part B: You are a community pharmacist, it is late October 2024, and a patient (age 64) presents for their flu vaccine after having received their COVID-19 shot 2 weeks ago. Your pharmacy has a practice of evaluating patients for additional vaccination needs and the patients adult vaccine history is below. Assume that the patient is up to date with all their childhood vaccines. Their current health conditions include asthma and diabetes. Vaccine typeDate ReceivedCOVID-1910/17/2024 12/22/2023 11/19/2022 1/29/2022 12/31/2021 FlU11/30/2023 12/31/2022 10/14/2021 10/21/2020 11/27/2019 10/11/2018 10/05/2017 9/28/2016 Hep-B10/10/2009 04/03/2009 03/01/2009 MMR03/01/2009 PCV 2007/25/2023 PPSV 2306/15/2017 Tdap09/25/2019 3. Which vaccines does this patient need and why? What information did you use to determine their needed vaccines and what resources did you use to confirm? 4. As you talk more with this patient, they are concerned about the ongoing additional new vaccines that keep getting recommended to them. They are frustrated about hearing they need more shots every time they talk to someone. What is your approach to this situation?
[Answered]: Part A: You are an ambulatory care pharmacist who…
Need help with your Cardiovascular Pharmacology case study or NCLEX preparation? Connect with a verified Nursing expert now.